Ajay Gupta's Headshot Dr. Ajay Gupta's Headshot

Ajay Gupta

Pediatric Oncology

Specializing In:

Pediatric sarcomas, Solid tumors, Developmental therapeutics, Early phase clinical trials, Adolescents and Young Adults (AYA)

About Ajay Gupta


I am a Pediatric Oncologist with a focus on solid tumors and the development of early phase clinical trials for children, adolescents, and young adults with cancer. I completed training in pediatric sarcoma and an MS in Translational Pharmacology.


Roswell Park Comprehensive Cancer Center

  • Assistant Professor of Oncology
  • Pediatric Oncology

Jacobs School Of Medicine And Biomedical Sciences, State University of New York at Buffalo

  • Assistant Professor of Pediatrics


Education and Training:

  • 2013 - MD - Albany Medical College, Albany, NY
  • 2019-2020 - MS - Translational Pharmacology, The Ohio State University, Columbus, OH


  • 2013-2016 - Pediatrics, Miami Children's Hospital, Miami, FL


  • 2019-2020 - Pediatric Sarcoma, Nationwide Children's Hospital, Columbus, OH
  • 2016-2019 - Pediatric Hematology/Oncology, Rainbow Babies & Children's Hospital, Cleveland, OH

Board Certification:

  • 2016 - American Board of Pediatrics

Professional Memberships:

  • 2019-present - American Society for Clinical Pharmacology & Therapeutics
  • 2019-present - International Society of Paediatric Oncology
  • 2019-present - American Society of Clinical Oncology
  • 2018-present - American Association of Cancer Research
  • 2017-present - American Society of Hematology
  • 2015-present - American Society of Pediatric Hematology/Oncology

Clinical Trials

Featured on Cancer Talk


1. Schulze TG, Detera-Wadleigh SD, Akula N, Gupta A, et al. Two variants in Ankyrin 3 (ANK3) are independent genetic risk factors for bipolar disorder. Molecular Psychiatry 2009 May;14(5):487-91.

2. Ferraro TN, Smith GG, Ballard D, Zhao H, Schwebel CL, Gupta A, et al. Quantitative trait loci for electrical seizure threshold mapped in C57BLKS/J and C57BL/10SnJ mice. Genes Brain Behav. 2011 Apr;10(3):309-15.

3. Gupta A, Schulze TG, Nagarajan V, Akula N, Corona W, Jiang XY, Hunter N, McMahon FJ, Detera-Wadleigh SD. Interaction networks of lithium and valproate molecular targets reveal a striking enrichment of apoptosis functional clusters and neurotrophin signaling. Pharmacogenomics J. 2012 Aug;12(4):328-41. http://www.ncbi.nlm.nih.gov/pubmed/21383773

4. Gupta A, Taslim C, Tullius BP, Cripe TP. Therapeutic modulation of the CD47-SIRPα axis in the pediatric tumor microenvironment: working up an appetite. Cancer Drug Resist. 2020;3.

5. Yonkof JR, Gupta A, Cripe TP, Abraham RS, et al; A Novel Pathogenic Variant in CARMIL2 (RLTPR) Causing CARMIL2 Deficiency and EBV-Associated Smooth Muscle Tumors. Front. Immunol. 2020 June: 11:884.